Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2014 2
2018 1
2020 4
2021 1
2022 4
2023 1
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Results by year

Filters applied: . Clear all
Page 1
Effect of Intravitreal Aflibercept vs Laser Photocoagulation on Treatment Success of Retinopathy of Prematurity: The FIREFLEYE Randomized Clinical Trial.
Stahl A, Sukgen EA, Wu WC, Lepore D, Nakanishi H, Mazela J, Moshfeghi DM, Vitti R, Athanikar A, Chu K, Iveli P, Zhao F, Schmelter T, Leal S, Köfüncü E, Azuma N; FIREFLEYE Study Group. Stahl A, et al. JAMA. 2022 Jul 26;328(4):348-359. doi: 10.1001/jama.2022.10564. JAMA. 2022. PMID: 35881122 Free PMC article. Clinical Trial.
[Alternative methods of surgical treatment of keratoconus].
Tereshchenko AV, Trifanenkova IG, Demianchenko SK, Erina YD, Golubeva YY, Pashtaev AN, Katmakov KI, Bulatov AR, Gelyastanov AM. Tereshchenko AV, et al. Among authors: trifanenkova ig. Vestn Oftalmol. 2024;140(2):85-90. doi: 10.17116/oftalma202414002185. Vestn Oftalmol. 2024. PMID: 38742503 Review. Russian.
[Botulinum therapy for acute esotropia].
Tereshchenko AV, Trifanenkova IG, Vydrina AA. Tereshchenko AV, et al. Among authors: trifanenkova ig. Vestn Oftalmol. 2022;138(2):31-36. doi: 10.17116/oftalma202213802131. Vestn Oftalmol. 2022. PMID: 35488560 Russian.
Intravitreal Aflibercept vs Laser Therapy for Retinopathy of Prematurity: Two-Year Efficacy and Safety Outcomes in the Nonrandomized Controlled Trial FIREFLEYE next.
Stahl A, Nakanishi H, Lepore D, Wu WC, Azuma N, Jacas C, Vitti R, Athanikar A, Chu K, Iveli P, Zhao F, Leal S, Schlief S, Schmelter T, Miller T, Köfüncü E, Fielder A; FIREFLEYE next Study Group. Stahl A, et al. JAMA Netw Open. 2024 Apr 1;7(4):e248383. doi: 10.1001/jamanetworkopen.2024.8383. JAMA Netw Open. 2024. PMID: 38687481 Free PMC article. Clinical Trial.
16 results